CATHERINE ZOCCHI: Open Payments
NPI 1982340469 · PENDLETON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 30 payments from 12 companies in 2025. Trend: 2023 $1,013 · 2024 $697 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $221 |
| ABBVIE INC. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Lundbeck LLC | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: XIFAXAN, CAPLYTA, REXULTI, VYEPTI, UBRELVY, GEMTESA, VRAYLAR, Ozempic.
Industry payments across SC — which companies pay providers there.
